EUVIMEDEUVIMED entdecken
Open Access

TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway

Zhangxian Xiao, Mingxi Li, Xiaoqian Zhang, Xuezhu Rong, Hongtao Xu

Oncology Reports · 2023

DOI: 10.3892/or.2023.8521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2023. Verfasst von Zhangxian Xiao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning 110122, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic AgentsHumansGefitinibPhosphorylationDrug Resistance, NeoplasmSignal TransductionErbB ReceptorsAutophagyCell Line, TumorATPases Associated with Diverse Cellular ActivitiesCell Cycle Proteins

Stichwörter der Autor:innen

EGFRNSCLCTRIP13autophagygefitinib resistance

Substanzen

GefitinibAntineoplastic AgentsErbB ReceptorsEGFR protein, humanTRIP13 protein, humanATPases Associated with Diverse Cellular ActivitiesCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning 110122, P.R. China.
  • Department of Pathology, The First Hospital of China Medical University, Heping, Shenyang, Liaoning 110001, P.R. China.

Zitieren

APA

Xiao, Z., Li, M., Zhang, X., Rong, X., & Xu, H. (2023). TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway. Oncology Reports. https://doi.org/10.3892/or.2023.8521

Vancouver

Xiao Z, Li M, Zhang X, Rong X, Xu H. TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway. Oncology Reports. 2023. doi:10.3892/or.2023.8521

BibTeX
@article{Xiao2023,
  author = {Xiao, Zhangxian and Li, Mingxi and Zhang, Xiaoqian and Rong, Xuezhu and Xu, Hongtao},
  title = {TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway},
  journal = {Oncology Reports},
  year = {2023},
  doi = {10.3892/or.2023.8521}
}
Kostenlos starten →